Los Institutos Nacionales de la Salud (NIH) están posponiendo el lanzamiento de su nuevo sitio web hasta el otoño para garantizar la mejor experiencia posible para todas las personas que utilizan nuestros sitios web para obtener información sobre la salud, investigación, oportunidades de financiamiento y otros recursos. Consulta las últimas actualizaciones y las preguntas frecuentes (disponibles en inglés).
Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.
Results from two years of patient followup in a randomized clinical trial suggest that argon laser therapy may be a safe and effective alternative to eyedrops as a first treatment for patients with newly diagnosed open-angle glaucoma.
Louis W. Sullivan, Secretary of Health and Human Services, has announced results of a clinical trial demonstrating a 50 percent improvement in surgical control of glaucoma in patients at high risk for blindness.
New findings from a nationwide clinical trial supported by theNational Eye Institute (NEI) provide further evidence that laser treatment is highly effective in preventing visual loss from diabetic eye disease.
Briefly freezing a portion of the eye’s surface can protect many premature infants against blindness from retinopathy of prematurity (ROP), a disease that causes visual loss in 2,600 infants in the United States annually.
New evidence from a nationwide study shows that treatment for some powerful beams of light can substantially reduce the risk of blindness for some people with severe eye disease caused by diabetes.